25 May 2013
Keywords: gsk, completes, id, biomed, 4b, purchase, canadian
Article | 19 December 2005
Canadian vaccine maker ID Biomedical has become a wholly-owned subsidiary of UK drug major GlaxoSmithKline as the latter's $1.4
billion acquisition ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 December 2005
24 May 2013
© 2013 thepharmaletter.com